Your browser doesn't support javascript.
loading
Specific Follicular Helper T Cell Signature in Takayasu Arteritis.
Desbois, A C; Régnier, P; Quiniou, V; Lejoncour, A; Maciejewski-Duval, A; Comarmond, C; Vallet, H; Rosenzwag, M; Darrasse-Jèze, G; Derian, N; Pouchot, J; Samson, M; Bienvenu, B; Fouret, P; Koskas, F; Garrido, M; Sène, D; Bruneval, P; Cacoub, P; Klatzmann, D; Saadoun, D.
Affiliation
  • Desbois AC; Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Régnier P; Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Quiniou V; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Lejoncour A; Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Maciejewski-Duval A; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Comarmond C; Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Vallet H; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Rosenzwag M; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Darrasse-Jèze G; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Derian N; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Pouchot J; Hôpital Européen Georges-Pompidou, AP-HP, Université Paris Descartes, Paris, France.
  • Samson M; Centre Hospitalier Universitaire Dijon Bourgogne, Université Bourgogne-Franche Comté, INSERM EFS Bourgogne-Franche Comté UMR1098, Dijon, France.
  • Bienvenu B; Centre Hospitalier Universitaire Caen, Caen, France.
  • Fouret P; Groupe Hospitalier Pitié-Salpétrière, Paris, France.
  • Koskas F; Groupe Hospitalier Pitié-Salpétrière, Paris, France.
  • Garrido M; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Sène D; Hôpital Lariboisière, Paris, France.
  • Bruneval P; Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
  • Cacoub P; Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Klatzmann D; Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Saadoun D; Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
Arthritis Rheumatol ; 73(7): 1233-1243, 2021 07.
Article in En | MEDLINE | ID: mdl-33538119
ABSTRACT

OBJECTIVE:

Our aim was to compare transcriptome and phenotype profiles of CD4+ T cells and CD19+ B cells in patients with Takayasu arteritis (TAK), patients with giant cell arteritis (GCA), and healthy donors.

METHODS:

Gene expression analyses, flow cytometry immunophenotyping, T cell receptor (TCR) gene sequencing, and functional assessments of cells from peripheral blood and arterial lesions from TAK patients, GCA patients, and healthy donors were performed.

RESULTS:

Among the most significantly dysregulated genes in CD4+ T cells of TAK patients compared to GCA patients (n = 720 genes) and in CD4+ T cells of TAK patients compared to healthy donors (n = 1,447 genes), we identified a follicular helper T (Tfh) cell signature, which included CXCR5, CCR6, and CCL20 genes, that was transcriptionally up-regulated in TAK patients. Phenotypically, there was an increase in CD4+CXCR5+CCR6+CXCR3- Tfh17 cells in TAK patients that was associated with a significant enrichment of CD19+ B cell activation. Functionally, Tfh cells helped B cells to proliferate, differentiate into memory cells, and secrete IgG antibodies. Maturation of B cells was inhibited by JAK inhibitors. Locally, in areas of arterial inflammation, we found a higher proportion of tertiary lymphoid structures comprised CD4+, CXCR5+, programmed death 1+, and CD20+ cells in TAK patients compared to GCA patients. CD4+CXCR5+ T cells in the aortas of TAK patients had an oligoclonal α/ß TCR repertoire.

CONCLUSION:

We established the presence of a specific Tfh cell signature in both circulating and aorta-infiltrating CD4+ T cells from TAK patients. The cooperation of Tfh cells and B cells might be critical in the occurrence of vascular inflammation in patients with TAK.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis / B-Lymphocytes / Takayasu Arteritis / T Follicular Helper Cells Limits: Aged80 Language: En Journal: Arthritis Rheumatol Year: 2021 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis / B-Lymphocytes / Takayasu Arteritis / T Follicular Helper Cells Limits: Aged80 Language: En Journal: Arthritis Rheumatol Year: 2021 Type: Article Affiliation country: France